GCP-unit at Aarhus University Hospital, Aarhus, Denmark
12
0
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
50%
6 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Reversal to Normoglycemia by Treating Prediabetes
Role: collaborator
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Role: collaborator
16α-18F-fluor-17β-estradiol PET/CT for Visualisation of Estrogen Receptor Positive Liver Metastases From Breast Cancer
Role: collaborator
PBC Induced Fatigue Treated With Thiamine
Role: collaborator
Alemtuzumab and CHOP in T-cell Lymphoma
Role: collaborator
Pregablin for Anxiety-comorbidity in Patients With Schizophrenia
Role: collaborator
Study of the Metabolism of Two Magnesium Supplements in Healthy Volunteers
Role: collaborator
Daily Magnesium-supplement for Severe Asthmatics
Role: collaborator
Bronchial Challenge Test of Magnesium-treated Asthmatics
Role: collaborator
Iron Substitution After Upper Gastro-Intestinal Bleeding
Role: collaborator
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Role: collaborator
Clinical Effect of Reflexology and Homeopathy Added to Conventional Asthma Management
Role: collaborator
All 12 trials loaded